3 Penny Stocks to Grab Before the Next Bull Run

How do you spot stocks that are most likely to explode in value?

Many experts will tell you to focus on earnings growth. If their earnings are growing now and have been growing for a while, the chances are that the company will continue to grow moving forward…

But that is only one part of the equation.

Focusing on earnings growth will give you a measure of a good company, but it won’t spot industries that are set to explode.

Now, investing in any company in a booming industry won’t get you very far.

You have to make sure you invest in the right company when looking for the next big thing…


“IMPERIUM:” The No. 1 Investment of the 2020s

Sponsored

Could this odd-looking machine really be the most transformative innovation in history?

Experts are screaming: “YES”!

Elon Musk calls it “amazing…”

A former Apple CEO says: “[It will] have a far bigger impact on humanity than the Internet.”

While a Harvard Ph.D. says it could “[surpass] the space, atomic, and electronic revolutions in its significance.”

It’s a technology I call “Imperium.”

And it’s about to spark the biggest investment mega trend in history… with one small Silicon Valley company at the center of it all.

To get all the details, click here now…


3.) Cocrystal Pharma Inc. (COCP)

Billionaire Investor: Steve Cohen

Steve Cohen, the legendary billionaire stock picker known for delivering huge returns for his clients at SAC Capital – one of the most successful hedge funds ever – is at it again.

But this time, he’s doing it with his new company Point72 Asset Management – which manages $17.2 billion for high-net-worth individuals.

Even if us normal folks can’t invest in the Point72 fund itself, we can still copy Cohen’s trades…

You see, Point72 is required to disclose all its holding publicly every quarter.

And last quarter, Cohen’s firm revealed a new position in one penny stock that caught my eye.

Cocrystal Pharma is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses.

[finviz ticker=COCP]

The company employs structure-based technologies and Nobel Prize-winning expertise to create first-and best-in-class antiviral drugs.

COCP is currently developing an oral broad-spectrum replication inhibitor called a non-nucleoside inhibitor – which is currently being evaluated in a Phase 2a study for the treatment of hepatitis C as part of an ultra-short therapy of four to six weeks.

Now if you don’t know what any of that means, it doesn’t matter. All you need to know is that it’s huge for the treatment of some of the world’s most-killer diseases… and potentially for investors too.

The stock shot up from $0.87 to $2.16 after Cohen announced his stake in the company late last year.

But now that’s it’s down to only $1.08 per share, that makes Cocrystal Pharma one of the more interesting penny stocks to watch for potentially huge gains in 2021.

If those Phase 2 trials turn out successful and the company moves on to Phase 3, the stock should get a boost. And if Phase 3 is successful, the stock could soar.

Sponsored: “Private Economy” worth Quadrillions (Grab Your Cut for $25)

2.) LiDAR Stock that Could Benefit from the Apple iCar

Apple Inc.’s (NASDAQ: AAPL) plan to build its own self-driving electric vehicle has been leaked…

It’s called “Project Titan” and the company is targeting 2024 for the car’s release.

Instead of being a self-driving taxi service like Alphabet Inc.’s (NASDAQ: GOOGL) Waymo, Apple’s goal is to sell affordable electric vehicles for the masses.

That means Apple would be in direct competition with Tesla’s (NASDAQ: TSLA) Models 3 and Y.

Personally, I expect Tim Cook and Apple to become a major threat to Tesla and Elon Musk.

Apple has a $135 billion war chest on its balance sheet to build the “iCar,” after all. That’s more money than any other U.S. company.

After selling billions of tech devices with rechargeable batteries for decades now, Apple understands battery technology as well as anyone.

Central to the company’s strategy to enter the EV market is a new battery design that could “radically reduce the cost of batteries and increase the vehicle’s range,” according to CNBC.

Like this… The “forever battery” that’s making gas cars obsolete.

If Apple is able to pull off an affordable EV with more range than the latest Tesla Model 3 and Y’s, it would certainly have long-term potential to boost AAPL stock.

Tesla has dropped 28% year-to-date compared to just a 7.5% loss for Apple so far in this volatile market.

But investors need to remember, it took Musk 17 years before he could finally turn Tesla into a profitable business…

For higher returns, you might want to look into these two LiDAR companies that could become the primary suppliers to Apple’s new car venture…

LiDAR is a method for measuring distances by illuminating the target with laser light and measuring the reflection with a sensor. This is for the self-driving component of the Apple car.

While Musk isn’t a fan of LiDAR technology himself, Apple might be on to something here…

They did recently employ LiDAR to some of their latest iPad Pros – so they’re likely collecting a ton of good information there that could help with the iCar.

Either way, it will be interesting to see who wins the race to produce fully autonomous driving electric vehicles that are affordable for regular folk like you and me.

Investors should pay attention to Velodyne Lidar Inc. (VLDR – only $4.15 per share).

This stock should pop if they become Apple’s main LiDAR suppliers for the new Apple iCar.

1.) The EV Battery Stock You Need to Know (#1 Tech Stock of 2021)


Sponsored

One tiny company started by a former Tesla employee could soon completely upend the entire energy sector, with its revolutionary new “Nano-Powder”.

This new “Nano-Powder” is so revolutionary in fact, that it could charge in just eight minutes (not hours), have a driving range of 9,200 miles on that charge, and last an incredible 12 Million miles before needing to be replaced.

But it doesn’t just stop with electric vehicles…

This technology is set to disrupt multiple sectors of the market, taking what’s now a $250 Billion niche and pushing it into a $51 Trillion Global Mega-Industry.

Its effects are set to be so large, the World Economic Forum is calling it “A transformation of unheard magnitude”

And this tiny company at the heart of this 20,300% market surge, holds 100 patents on this technology.

This new industry is poised to create more new millionaire investors over the next decade than any other.

But the window to get in before the biggest potential gains are had is closing FAST.

Click here for all the details on this company.


Electrameccanica Vehicles Corp Ltd. (NASDAQ: SOLO) is a Canadian designer and manufacturer of environmentally efficient electric vehicles (EVs).

The company’s flagship vehicle is a single-seat EV called the SOLO (hence the company’s ticker symbol).

SOLO believes their three-wheeled vehicle will revolutionize the urban driving experience – that includes commuting, delivery, and shared mobility.

In its Q4 2020 report, Electrameccanica said their new EV factory in Mesa, Arizona will create 500 jobs and will have the capacity to produce 20,000 SOLO vehicles.

I’m bullish on the stock because it’s trading at an attractive price-to-book ratio of 1.59 ($129 million of cash compared to its $205 million total valuation).

That’s 21.7 times LESS than Tesla’s P/B ratio of 34.5.

The bottom line is: SOLO is a great way to get in on the ground floor of a cheap company ($1.78 per share) that could very well play a crucial part in the EV boom.

$2 EV Stock No One's Talking About

This company is a sneaky EV play that no one’s talking about. They’re producing an odd variation on the traditional EV that has consumers raving.

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

$30 Stock Freaking Out Billionaires

This stock is an industry leader in a robotics technology that is freaking out billionaires (trading for just $30).

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

The Best TaaS Stock Right Now

This company is set to corner the market in a self-driving technology that  could fundamentally change our entire society – much like the internet did.

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Up to 20,000 IPOs All in One Day

A radical $2.1 quadrillion shift is coming to the financial markets.

Some are calling it G.T.E. and Mark Cuban, Elon Musk, Richard Branson, and even banks like J.P. Morgan are invested in the tech behind it.

Just $25 could get you in alongside these billionaires. 

Enter your email address to receive the video that reveals it all.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

53-cent Biotech Stock with $2 Price Target

Steve Cohen, the billionaire stock picker known for running one of the most successful hedge funds ever, has poured millions into the first stock, and it’s trading for only 53 cents.

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works